We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$1.96B
AUM Growth
+$74.6M
Cap. Flow
-$10.1M
Cap. Flow %
-0.51%
Top 10 Hldgs %
7.82%
Holding
1,940
New
581
Increased
351
Reduced
365
Closed
635

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$16.3M
2
INTU icon
Intuit
INTU
+$11.7M
3
RCL icon
Royal Caribbean
RCL
+$11.2M
4
ABBV icon
AbbVie
ABBV
+$11M
5
HUM icon
Humana
HUM
+$10.3M

Top Sells

Rank Stock Value
1
CMI icon
Cummins
CMI
+$12.6M
2
EA icon
Electronic Arts
EA
+$12.5M
3
DLTR icon
Dollar Tree
DLTR
+$11.3M
4
TJX icon
TJX Companies
TJX
+$11.1M
5
AMGN icon
Amgen
AMGN
+$10.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.07%
2 Technology 14.04%
3 Healthcare 13.1%
4 Financials 11.42%
5 Industrials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHRN
1251
ChronoScale Holdings
CHRN
$2.94B
$55K ﹤0.01%
+204
New +$72.4K
CXRX
1252
DELISTED
Concordia International Corp. Common Stock
CXRX
$55K ﹤0.01%
+47,049
New +$64.2K
OCRX
1253
DELISTED
Ocera Therapeutics, Inc.
OCRX
$54K ﹤0.01%
48,077
-34,320
-42% -$36.8K
ARMP icon
1254
Armata Pharmaceuticals
ARMP
$189M
$53K ﹤0.01%
4,227
+1,223
+41% +$15.7K
FCSC
1255
DELISTED
Fibrocell Science Inc.
FCSC
$52K ﹤0.01%
+3,415
New +$55.2K
IPCI
1256
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$52K ﹤0.01%
+5,282
New +$75.4K
ARTX
1257
DELISTED
Arotech Corporation
ARTX
$50K ﹤0.01%
+12,000
New +$43.4K
BCLI
1258
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$49K ﹤0.01%
+793
New +$51.3K
INSG icon
1259
Inseego
INSG
$114M
$49K ﹤0.01%
3,300
+2,169
+192% +$27.8K
VHI icon
1260
Valhi
VHI
$385M
$49K ﹤0.01%
1,695
+178
+12% +$5.72K
AGTC
1261
DELISTED
Applied Genetic Technologies Corporation
AGTC
$49K ﹤0.01%
12,585
-42,656
-77% -$196K
AVID
1262
DELISTED
Avid Technology Inc
AVID
$48K ﹤0.01%
+10,746
New +$50.9K
ATRS
1263
DELISTED
Antares Pharma, Inc.
ATRS
$45K ﹤0.01%
+14,014
New +$43.2K
CASC
1264
DELISTED
Cascadian Therapeutics, Inc.
CASC
$44K ﹤0.01%
10,761
-758
-7% -$2.9K
LRMR icon
1265
Larimar Therapeutics
LRMR
$398M
$43K ﹤0.01%
1,024
-2,110
-67% -$87.7K
FLNA
1266
Filana Therapeutics
FLNA
$43.5M
$43K ﹤0.01%
10,796
-14,159
-57% -$50.6K
CBK
1267
DELISTED
Christopher & Banks Corporation
CBK
$40K ﹤0.01%
29,799
-53,200
-64% -$73.6K
RIGL icon
1268
Rigel Pharmaceuticals
RIGL
$692M
$39K ﹤0.01%
1,550
-1,760
-53% -$42.8K
DHX icon
1269
DHI Group
DHX
$164M
$38K ﹤0.01%
14,668
-23,450
-62% -$53.5K
ECYT
1270
DELISTED
Endocyte, Inc. Common Stock
ECYT
$38K ﹤0.01%
27,156
-127,975
-82% -$178K
FLL icon
1271
Full House Resorts
FLL
$84.5M
$37K ﹤0.01%
+13,415
New +$34.6K
LTRX icon
1272
Lantronix
LTRX
$244M
$36K ﹤0.01%
14,871
-6,801
-31% -$14.8K
CGNT
1273
DELISTED
Cogentix Medical, Inc.
CGNT
$36K ﹤0.01%
+14,412
New +$31.6K
SRRA
1274
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$35K ﹤0.01%
+567
New +$33.3K
CORV
1275
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$35K ﹤0.01%
+16,718
New +$56.9K
49 50
51
52 53

Similar funds

MA
MANA Advisors New York $3.06M AUM 7.13% 1-Year Est. Return
FFIM
Founders Fund III Management San Francisco, California $435K AUM
LC
Lunia Capital Dallas, Texas $4.49M AUM 42.82% 1-Year Est. Return
YEPV
Yorktown Energy Partners VI New York $6.21M AUM 74.4% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM

A.R.T. Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, A.R.T. Advisors held 1,940 positions worth $1.96B, up 4% from $1.89B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

A.R.T. Advisors's Q3 2017 filing shows 581 new, 351 increased, 365 reduced and 635 closed positions. Its largest new stake was General Motors: 280,300 shares worth $11.3M. The largest sale was Cummins, an estimated $12.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

  • A.R.T. Advisors's largest Q3 2017 buy was General Motors: 280,300 shares worth $11.3M.
  • A.R.T. Advisors added most to Meta Platforms (Facebook) in Q3 2017, an estimated $16.3M increase.
  • A.R.T. Advisors's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $12.5M.
  • A.R.T. Advisors fully exited Cummins in Q3 2017, selling an estimated $12.6M.
  • A.R.T. Advisors's ten largest holdings make up 7.8% of its $1.96B portfolio in Q3 2017.
  • A.R.T. Advisors opened 581 new positions and closed 635 in Q3 2017.
  • A.R.T. Advisors's portfolio value rose 4% quarter-over-quarter to $1.96B.

Based on A.R.T. Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.